Back to sessions
Sep 28
Education

EDU 14 - Gen X Cancers: The Rising Incidence and Challenges in Management for Patients Diagnosed with Cancer in their 40s and 50s

08:00am - 09:00am ET

MODERATOR(S)

Nirav Kapadia, MD, MS - Dartmouth-Hitchcock Medical Center

session DESCRIPTION

Cancer patients in their 40s and 50s have unique clinical and social characteristics that may influence their response and survivorship from radiation therapy. Patients meeting the definition for adolescent and young adult (AYA) cancer generally are defined as being of age 15 through 39 and have specialized programs of research focus and survivorship. Patients over the age of 65 are eligible for Medicare and comprise the bulk of new cancer diagnoses. Patients in between these age groups are projected to have the greatest increase in cancer incidence than previous generations. This generation, known as "Gen X," is currently in their 40s and 50s, and encompasses a group of patients with unique clinical and psychosocial issues, such as family care, reliance on employment for medical care, elevated risk of second malignancy (relative to older patients), and waning fertility. This session will review the rising incidence of cancers for patients in their 40s and 50s, review the rising incidence of cancers for these patients, review the social challenges (family care, employment, insurance), and discuss the state of knowledge with regards to radiotherapeutic care of these patients with a focus on second malignancy risk.

learning objectives

  1. Discuss the special clinical and social needs of patients in their 40s and 50s.
  2. Discuss the current epidemiology of cancer incidence for patients in their 40s and 50s.
  3. Discuss the unique second malignancy risks for patients in their 40s and 50s.

Credits

AMA PRA Category 1 Credits: 1.00

Rate This Session

Presentations